MAGNESIUM CITRATE - CAP 100MG 100 MG
MAGNESIUM (MAGNESIUM CITRATE) : 100 MG · DIN 02201917 · SISU INC.
Health Canada status: CANCELLED POST MARKET
What is MAGNESIUM CITRATE - CAP 100MG?
MAGNESIUM CITRATE - CAP 100MG 100 MG contains MAGNESIUM (MAGNESIUM CITRATE) : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02201917, held by SISU INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02201917 |
|---|---|
| Brand name | MAGNESIUM CITRATE - CAP 100MG |
| Generic / active ingredient | MAGNESIUM (MAGNESIUM CITRATE) : 100 MG |
| Manufacturer | SISU INC. |
| Strength | 100 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A12CC04 MAGNESIUM CITRATE |
| AHFS class | 88:29.00* ; See footnote |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Aug-2009 |
| Original market date | 1997-02-25 00:00:00 |
Is MAGNESIUM CITRATE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code A12CC04 MAGNESIUM CITRATE. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MAGNESIUM 150 MG | 150 MG | CAPSULE | REGIME INDUSTRIES LTD. | CANCELLED POST MARKET | DIN 02245975 |
| MAGNESIUM 150 MG | 150 MG | CAPSULE | PREFERRED NUTRITION INC. | CANCELLED POST MARKET | DIN 02248877 |
| MAGNESIUM CITRATE 150MG | 150 MG | CAPSULE | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | DIN 02243649 |
| MAGNESIUM CITRATE CAP 150MG | 150 MG | CAPSULE | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | DIN 01942115 |
| MAGNESIUM CITRATE CAPLET 300MG | 300 MG | TABLET | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 01900390 |
| MAGNESIUM TABLETS 200MG | 200 MG | TABLET | ROYAL BODYCARE CANADA INC. | CANCELLED POST MARKET | DIN 02057506 |
Who else supplies MAGNESIUM CITRATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MAGNESIUM CITRATE appears in 235 registered pack listings across 12 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.